California-based Metropolis of Hope has now accomplished its acquisition of Most cancers Remedy Facilities of America (CTCA), making the mixed group one of many largest most cancers analysis and remedy services in america.
The mixed group now has 575 physicians and greater than 11,000 staff and is anticipated to care for about 115,000 sufferers annually.
Metropolis of Hope, a Nationwide Most cancers Institute–designated complete most cancers middle, is situated close to Los Angeles. It at the moment includes its principal campus and a community of scientific care places throughout Southern California. A brand new campus is scheduled to open this 12 months in Irvine, California, about 50 miles south of the principle middle.
The acquisition of CTCA expands its attain into three new states — Arizona, Illinois, and Georgia — with an extra 41 scientific community places.
Commenting on the completion of the deal, Robert Stone, president and CEO of Metropolis of Hope, stated in a press release: “With the completion of this acquisition, Metropolis of Hope and Most cancers Remedy Facilities of America are combining complementary strengths…. Collectively, we’re creating a brand new mannequin for the way most cancers care is delivered, leveraging real-world most cancers care expertise to tell scientific innovation and making tomorrow’s new discoveries obtainable to the individuals who want them immediately.”
Metropolis of Hope introduced in December 2020 that it could purchase CTCA for $390 million, as beforehand reported by Medscape Medical New.
On the time, Pat Basu MD, MBA, president and CEO of CTCA, stated that they have been excited concerning the deal. “By the shared, patient-centric values of each organizations and expanded entry on account of the collaboration, most cancers sufferers throughout the nation would be the final beneficiaries of this relationship,” he stated. Basu will stay CEO of CTCA and report back to Robert Stone.
Controversies and Closures
CTCA is a nationwide oncology community of hospitals and outpatient care facilities that gives an built-in strategy to care, together with surgical procedure, radiotherapy, chemotherapy, immunotherapy, and developments in precision drugs with supportive therapies to handle unwanted effects and improve high quality of life throughout remedy and into survivorship.
Nevertheless, it seems to have run into monetary issues. Throughout 2021, CTCA closed a middle in Tulsa, Oklahoma, and bought off belongings from a Philadelphia-based hospital.
As well as, for the previous 10 years, CTCA had been concerned in a sequence of controversies. These embody a 2013 investigation into alleged questionable practices designed to spice up its mortality statistics, in addition to an evaluation of most cancers middle promoting practices that confirmed that CTCA spent $101.7 million on promoting in 2014. Extra lately, a 2019 report confirmed that CTCA’s excessive promoting expenditures didn’t correlate with higher affected person outcomes compared with different facilities.
Now that it has been acquired, CTCA will transition from a non-public for-profit firm to a nonprofit group, in accordance with Metropolis of Hope.
For extra from Medscape Oncology, be a part of us on Twitter and Fb.